查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1392066

救援吸入器市场：按产品类型、按适应症、按患者类型、按剂型、按最终用户、按地区

Rescue Inhaler Market, By Product Type, By Indication, By Patient Type, By Dosage Form, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3个工作天内

价格
简介目录

救援吸入器市场规模预计将从 2023 年的 155 亿美元增加到 2030 年的 279 亿美元，预测期内复合年增长率为 8.8%。

报告范围 报告详情
基准年 2022年 2023年市场规模 155亿美元
实绩资料 2018-2021 预测期 2023-2030
预测期复合年增长率 8.80% 2030年市场规模预测 279亿美元
图 1. 2023 年按地区分類的救援吸入器市场占有率(%)
救援吸入器市场-IMG1

救援吸入器，也称为缓解吸入器，是患有气喘或慢性阻塞性肺病(COPD) 等呼吸系统疾病的人常用的药物装置。它含有速效支气管扩张剂，可在气喘发作或呼吸困难时打开气道。这种药物可以快速缓解喘息、气短和胸闷等症状。救援吸入器可以快速缓解症状，但不能治疗症状的根本原因。它是管理急性呼吸道症状和改善患者生活品质的重要工具。

市场动态：

呼吸系统疾病盛行率的上升、老年人口的增加以及医疗保健支出的增加预计将在预测期内推动全球救援吸入器市场的成长。此外，技术进步预计也将在预测期内推动全球救援吸入器市场的成长。新兴市场的高成长潜力、居家照护需求的成长、气喘生技药品的市场开拓以及对呼吸照护远端医疗医疗的日益关注将推动全球救援吸入器市场在预测期内带来机会。

然而，严格的监管要求、吸入器的副作用以及吸入器的高成本预计将阻碍预测期内救援吸入器市场的成长。

本研究的主要特点

  • 该报告详细分析了救援吸入器市场，并提供了以2022年为基准年的预测期（2023-2030）的市场规模和年复合成长率（CAGR%）。
  • 它还阐明了不同细分市场的潜在商机，并解释了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
  • 它根据公司亮点、产品系列、主要亮点、财务实绩和策略等参数，介绍了救援吸入器市场的主要企业。
  • 该报告的见解使行销人员和公司负责人能够就未来的产品发布、类型升级、市场扩张和行销策略做出资讯的决策。
  • 救援吸入器市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 透过用于分析救援吸入器市场的各种策略矩阵，将有助于相关人员做出决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 假设
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

  • 市场动态
    • 促进因素
  • 呼吸道疾病盛行率上升
  • 老年人口增加
  • 增加产品核准
    • 抑制因素
  • 严格的监管要求
  • 产品召回
  • 吸入器很贵
    • 机会
  • 呼吸照护远端医疗医疗日益受到关注
  • 气喘生物製药的开发
  • 新兴市场的高成长潜力
  • 影响分析
  • 主要亮点
  • 监管场景
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 併购场景

第四章救援吸入器市场－冠状病毒（COVID-19）大流行的影响

  • 新型冠状病毒感染疾病（COVID-19）的流行病学
  • 供需面分析
  • 经济影响

第五章救援吸入器市场，依产品类型，2018-2030

  • 定量吸入器
  • 干粉吸入器
  • 喷雾器
  • 软雾吸入器
  • 其他的

第六章 救援吸入器市场，依适应症划分，2018-2030 年

  • 气喘
  • COPD
  • 过敏性鼻炎
  • 肺动脉高血压
  • 其他的

第 7 章 救援吸入器市场，依病患类型，2018-2030 年

  • 成人
  • 儿童

第 8 章救援吸入器市场，按剂型，2023-2030 年

  • 胶囊
  • 解决方案
  • 暂停
  • 其他的

第 9 章 救援吸入器市场，依最终使用者划分，2018-2030 年

  • 居家照护环境
  • 医院和诊所

第10章救援吸入器市场，按地区，2018-2030

  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 南非
  • 中部非洲

第十一章竞争形势

  • GSK plc.
  • Teva Pharmaceutical Industries Ltd.
  • Cipla Inc.
  • PARI Pharma GmbH
  • Lupin
  • AstraZeneca
  • Boehringer Ingelheim International GmbH.
  • Novartis
  • Pfizer
  • Sunovion Pharmaceuticals
  • 3M
  • OMRON Healthcare Co., Ltd.
  • Koninklijke Philips NV
  • Invacare
  • Schiller
  • Teleflex Incorporated

第12章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6208

The Rescue Inhaler Market size is expected to reach US$ 27.9 billion by 2030, from US$ 15.5 billion in 2023, at a CAGR of 8.8% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 15.5 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 8.80% 2030 Value Projection: US$ 27.9 Bn
Figure 1. Rescue Inhaler Market Share (%), By Region, 2023
Rescue Inhaler Market - IMG1

A rescue inhaler, also known as a reliever inhaler, is a medication device commonly used by individuals with respiratory conditions such as asthma or chronic obstructive pulmonary disease (COPD). It contains a fast-acting bronchodilator medication that helps open up airways during an asthma attack or breathing difficulties. This medication quickly eases symptoms like wheezing, shortness of breath, and chest tightness. Rescue inhalers offer rapid relief, but they do not treat the underlying cause of the condition. They are an essential tool for managing acute respiratory symptoms and improving the patient's quality of life.

Market Dynamics:

Rising prevalence of respiratory diseases, increasing geriatric population, and rising healthcare expenditure are anticipated to drive growth of the global rescue inhaler market over the forecast period. Moreover, technological advancements is also expected to boost the growth of the global rescue inhaler market over the forecast period. High growth potential in emerging markets, growing demand for home care settings, development of biologics for asthma, rising focus on telehealth for respiratory care are expected to create growth opportunities for the global rescue inhaler market during the forecast period.

However, stringent regulatory requirements, side effects of inhalers, and high cost of inhalers are expected to hamper growth of the rescue inhaler market over the forecast period.

Key features of the study:

  • This report provides an in-depth analysis of the rescue inhaler market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the rescue inhaler market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include GSK plc., Teva Pharmaceutical Industries Ltd., Cipla Inc., PARI Pharma GmbH, Lupin, AstraZeneca, Boehringer Ingelheim International GmbH., Novartis, Pfizer, Sunovion Pharmaceuticals, 3M, OMRON Healthcare Co., Ltd., Koninklijke Philips N.V., Schiller, and Teleflex Incorporated
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The rescue inhaler market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the rescue inhaler market

Detailed Segmentation:

  • By Product Type:
    • Metered Dose Inhalers
    • Dry Powder Inhalers
    • Nebulizers
    • Soft Mist Inhalers
    • Others
  • By Indication:
    • Asthma
    • COPD
    • Allergic Rhinitis
    • Pulmonary Arterial Hypertension
    • Others
  • By Patient Type:
    • Adult
    • Pediatric
  • By Dosage Form:
    • Capsules
    • Solution
    • Suspension
    • Others
  • By End User:
    • Home Care Settings
    • Hospitals & Clinics
  • By Region:
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profile:
    • GSK plc.
    • Teva Pharmaceutical Industries Ltd.
    • Cipla Inc.
    • PARI Pharma GmbH
    • Lupin
    • AstraZeneca
    • Boehringer Ingelheim International GmbH.
    • Novartis
    • Pfizer
    • Sunovion Pharmaceuticals
    • 3M
    • Omron Healthcare
    • Koninklijke Philips N.V.
    • Invacare
    • Schiller
    • Teleflex Incorporated

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Indication
    • Market Snippet, By Patient Type
    • Market Snippet, By Dosage Form
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Rising prevalence of respiratory diseases
  • Increasing geriatric population
  • Increasing Product Approval
    • Restraints
  • Stringent regulatory requirements
  • Product Recall
  • High cost of inhalers
    • Opportunities
  • Rising focus on telehealth for respiratory care
  • Development of biologics for asthma
  • High growth potential in emerging markets
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Rescue Inhaler Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Rescue Inhaler Market, By Product Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Metered Dose Inhalers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Dry Powder Inhalers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Nebulizers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Soft Mist Inhalers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

6. Rescue Inhalers Market, By Indication, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Asthma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • COPD
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Allergic Rhinitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Pulmonary Arterial Hypertension
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

7. Rescue Inhalers Market, By Patient Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Adult
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Pediatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

8. Rescue Inhalers Market, By Dosage Form, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Capsules
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Solution
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Suspension
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

9. Rescue Inhalers Market, By End User, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Home Care Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Hospitals & Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

10. Rescue Inhalers Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country 2019 -2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • UK
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
  • North Africa
  • South Africa
  • Central Africa

11. Competitive Landscape

  • GSK plc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Teva Pharmaceutical Industries Ltd.
  • Cipla Inc.
  • PARI Pharma GmbH
  • Lupin
  • AstraZeneca
  • Boehringer Ingelheim International GmbH.
  • Novartis
  • Pfizer
  • Sunovion Pharmaceuticals
  • 3M
  • OMRON Healthcare Co., Ltd.
  • Koninklijke Philips N.V.
  • Invacare
  • Schiller
  • Teleflex Incorporated
  • Analyst Views

12. Section

  • Research Methodology
  • About us